Cargando…
Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide
Although many treatments have been applied to treat hormone-refractory prostate cancer (HRPC), therapeutic outcome is not altogether satisfactory. In the case of locally recurring HRPC, uncontrolled gross hematuria, dysuria, and scalding are often experienced. We report a patient who improved follow...
Autores principales: | Uemura, Keiichiro, Nishihara, Kiyoaki, Hayashi, Tokumasa, Tomiyasu, Katsuro, Matsuoka, Kei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491188/ https://www.ncbi.nlm.nih.gov/pubmed/22203121 http://dx.doi.org/10.1007/s10156-011-0352-9 |
Ejemplares similares
-
Metabolism of ifosfamide during a 3 day infusion.
por: Hartley, J. M., et al.
Publicado: (1994) -
Efficacy of ifosfamide, dacarbazine, doxorubicin and cisplatin in human sarcoma xenografts.
por: Budach, W., et al.
Publicado: (1994) -
A useful treatment for patients with advanced mixed-type small cell neuroendocrine carcinoma of the prostate: A case report
por: UEMURA, KEI-ICHIRO, et al.
Publicado: (2013) -
Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma
por: Requilé, Annelies, et al.
Publicado: (2017) -
High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma
por: Sanfilippo, Roberta, et al.
Publicado: (2014)